Institut Gustave Roussy
Gustave Roussy is a cancer-research institute and European Cancer Centre. It is a centre for patient care, research and teaching, and patients with all types of cancer can be treated there.
Gustave Roussy | |
---|---|
1934 inauguration | |
Geography | |
Location | Villejuif, France |
Organisation | |
Type | Research center, Teaching Hospital |
Services | |
Emergency department | Yes |
Beds | 457 |
History | |
Opened | 1926 |
Links | |
Website | https://www.gustaveroussy.fr/en |
Lists | Hospitals in France |
It is located in Villejuif, South Paris, France. It is named after Gustave Roussy, a Swiss-French neuropathologist.
Notable people
- Gustave Roussy, first director (1921–1947)
- Tabaré Vázquez
- Maurice Tubiana, fifth director (1982–1988) and member of the French Academy of Sciences
- Georges Mathé, oncologist and immunologist who performed in 1959 the first successful bone marrow transplant not performed on identical twins.[1]
- Frédéric Triebel, discoverer of the immune checkpoint molecule LAG3, worked at the institute from 1986 until around 2001
- Barbara Tudek (1952-2019), biologist and professor who served as president of the Polish section of the European Environmental Mutagenesis and Genomics Society
Awards and Rankings
In 2020, the Institut Gustave Roussy was ranked 5th among the World's Best Specialized Hospitals.[2]
Incidents
In 2017, a virologist from the Institut Gustave Roussy was sentenced to 5 years in prison for poisoning colleagues with sodium azide in 2014.[3]
Notes
- Martin, Douglas (20 October 2010). "Dr. Georges Mathé, Transplant Pioneer, Dies at 88". New York Times.
- https://www.newsweek.com/worlds-best-specialized-hospitals-2021/oncology
- "A l'Institut Gustave-Roussy, un scientifique empoisonne ses collègues". Franceinfo (in French). 2017-12-13. Retrieved 2018-09-10.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.